Press Releases
Feb. 6, 2026
OilXCoin Launches Secondary Market Trading and Acquires O&G Lease in Kansas, USA
Indeterminate
GlobeNewswire, Inc.
Nov. 18, 2025
OSCE training empowers young experts from Central Asia, South-East Europe and Mediterranean Partners for Co-operation regions in inclusive project design and digital research
Gov't Institution
Organization for Security and Co-operation in Europe
Owner: Organization for Security and Co-operation in Europe
Nov. 13, 2025
Abaxx Technologies Acquires Strategic Position in ARTEX AG, Extending Capabilities in Europe and to New Markets in Fine Art
Indeterminate
GlobeNewswire, Inc.
Jul. 7, 2025
Liechtenstein Bankers Association CEO Featured in CEO Insight: Driving Sustainable Finance and Innovation
Neutral
EIN Presswire
Jan. 22, 2026
Open Cosmos Takes First Major Step Towards Its Low Earth Orbit Constellation With Landmark Satellite Launch
Indeterminate
GlobeNewswire, Inc.
Apr. 28, 2025
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
Indeterminate
GlobeNewswire, Inc.
Feb. 28, 2025
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
Indeterminate
GlobeNewswire, Inc.
Mar. 3, 2025
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
Indeterminate
GlobeNewswire, Inc.
Mar. 3, 2025
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
Indeterminate
GlobeNewswire, Inc.
Mar. 17, 2025
4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion
Indeterminate
GlobeNewswire, Inc.
Jan. 28, 2026
AMERICAN SWISS FOUNDATION CO-HOSTS 2026 FRIENDSHIP COCKTAIL AT THE WORLD ECONOMIC FORUM
Neutral
EIN Presswire
Jan. 2, 2026
Introducing Obyte Friends: Rewards for Connections and Active Staking
Neutral
EIN Presswire
Dec. 19, 2025
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Indeterminate
GlobeNewswire, Inc.
Dec. 19, 2025
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Indeterminate
GlobeNewswire, Inc.
Jan. 19, 2026
CEO Insight Releases New 2026 Issue Examining Trust, Governance and Global Connectivity
Neutral
EIN Presswire